Supplementary Data for "National trends in multi-modality keloid treatment claims from 2017-2020: an IBM Marketscan Study."
Published: 20 June 2024| Version 4 | DOI: 10.17632/wymkh93mv2.4
Contributors:
David Xiang, Description
This file contains the following supplementary material: - National cost trends of keloid treatments and shows the year to year trend of copay and gross payments to a provider from 2017 to 2020 across all three keloid treatment modalities. - Breakdown of Marketscan industries by enrollee counts - Bundled surgical procedure information on patients receiving exicision or biopsy removal before XRT, as well as ILK after a surgical procedure.
Files
Institutions
Harvard Medical School, Massachusetts General Hospital
Categories
Dermatology